A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis

NCT00236028 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

607

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Infliximab

Sponsor

Centocor, Inc.